LICENSE AGREEMENT BETWEEN PALISADE BIO, INC. AND THE REGENTS OF THE UNIVERSITY OF CALIFORNIA FOR CASE NO. [***] CASE NO. [***]License Agreement • March 17th, 2022 • Palisade Bio, Inc. • Biological products, (no disgnostic substances) • California
This agreement (“Agreement”) is made by and between Palisade Bio, Inc., a Delaware corporation having an address at 5800 Armada Dr, Suite 210, Carlsbad, California 92008 (together with its Affiliates, including Leading BioSciences, Inc., “LICENSEE”) and The Regents of the University of California, a California public corporation having its statewide administrative offices at 1111 Franklin Street, Oakland, California 94607-5200 (“UNIVERSITY”), represented by its San Diego campus having an address at University of California, San Diego, Office of Innovation and Commercialization, Mail Code 0910, 9500 Gilman Drive, La Jolla, California 92093-0910 (“UCSD”).
ASSET TRANSFER AGREEMENTAsset Transfer Agreement • March 17th, 2022 • Palisade Bio, Inc. • Biological products, (no disgnostic substances) • California
This ASSET TRANSFER AGREEMENT (this “Agreement”) is entered into as of October 18, 2021 (the “Agreement Date”), by and between Alto Neuroscience, Inc., a Delaware corporation (“Buyer”), and Palisade Bio, Inc. (formerly Seneca Biopharma, Inc.), a Delaware corporation (“Seller”) (Buyer and Seller are each referred to herein as a “Party” and together as the “Parties”).
